Forskolin is one such compound, known for its ability to boost cAMP levels within cells, which in turn can enhance various protein phosphorylation processes. This elevation of cAMP can lead to changes in the environment of Arylsulfatase G, potentially affecting its function. Another compound, IBMX, also aims to raise intracellular cAMP levels but does so by inhibiting phosphodiesterases-enzymes responsible for the breakdown of cAMP. The result is similar to that of Forskolin, leading to an indirect impact on the activity of Arylsulfatase G. Y-27632 acts on a different pathway, targeting the Rho-associated kinase to influence the dynamics of the cytoskeleton, which may alter the cellular context for Arylsulfatase G and thus its activity.
Activators like PMA interact with protein kinase C, a pivotal player in signal transduction and cellular regulation processes. Activating protein kinase C can modulate a variety of cellular functions that could intersect with the pathways involving Arylsulfatase G. Additionally, U0126 and PD98059 are known to inhibit MEK, an element of the MAPK/ERK pathway, which is a key regulator of gene expression and cellular growth, and could therefore have implications for Arylsulfatase G. Compounds targeting the PI3K/AKT/mTOR pathway, such as LY294002 and Rapamycin, are important for cell growth and metabolism. Changes in these pathways might affect Arylsulfatase G's role in the cell. The activity of growth factor receptors can be influenced by specific inhibitors, such as those for the EGF and IGF-1 receptors, which might have downstream effects on Arylsulfatase G. Guanosine 5'-O-(3-thiotriphosphate) tetralithium salt, a non-hydrolyzable GTP analog, binds to G-proteins, affecting G-protein-coupled signaling pathways and potentially the activity of Arylsulfatase G. Nicotinamide mononucleotide, which enhances NAD+ biosynthesis, plays a critical role in energy metabolism. This boost in cellular energy production can create an environment that may affect the function of various enzymes, including Arylsulfatase G.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Elevates cAMP levels, which can enhance protein phosphorylation and can affect the function of Arylsulfatase G. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
Inhibits phosphodiesterases, increasing cAMP levels and can promote protein phosphorylation affecting Arylsulfatase G. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Inhibits Rho-associated kinase, can alter cytoskeletal dynamics and influence Arylsulfatase G's role in the cell. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Activates protein kinase C, can modulate several cellular functions that include pathways involving Arylsulfatase G. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
Inhibits MEK, affecting the MAPK/ERK pathway which can influence Arylsulfatase G activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
Inhibits MEK, leading to altered MAPK/ERK signaling which can affect Arylsulfatase G activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Inhibits PI3K, affecting pathways that can influence Arylsulfatase G's role in cellular processes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibits mTOR, can affect cellular growth and metabolism pathways that include Arylsulfatase G. | ||||||
IGF-1R Inhibitor, PPP | 477-47-4 | sc-204008A sc-204008 sc-204008B | 1 mg 10 mg 100 mg | $112.00 $199.00 $877.00 | 63 | |
Inhibits IGF-1 receptor, affecting downstream signaling that can influence Arylsulfatase G. | ||||||
Guanosine 5′-O-(3-thiotriphosphate) tetralithium salt | 94825-44-2 | sc-202639 | 10 mg | $456.00 | ||
Non-hydrolyzable GTP analog, binds to G-proteins and can affect signaling pathways involving Arylsulfatase G. |